Gilead Sues Teva for Infringing AIDS Drug I

On Friday, Gilead Sciences, a Californian drugmaker reported filing a suit in U.S. District Court of New York, charging Teva with infringing patents related to a component of a drug to treat HIV-1 infection in adults.

This entry was posted on Monday, December 15th, 2008 at 8:22 am and is filed under drugs, pharmaceuticals, pharmaceuticals and Biotechnology, Teva. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out / Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out / Change )

Cancel

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 93 other followers